
- Telehealth Visits
- Insurance plan information

Michelle E. Guy, MD
Internal Medicine • Obesity Medicine- Telehealth Visits
- Insurance plan information



Michelle E. Guy, MD
Internal Medicine • Obesity Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Michelle Guy is a specialist in internal medicine and obesity medicine. She provides primary care.
Guy earned her medical degree from the University of Missouri School of Medicine. She completed a residency in primary care at Cambridge Health Alliance, an affiliate of Harvard Medical School. She served as chief resident.
Guy teaches UCSF medical students and residents in the clinic setting.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, Cambridge Hospital
Internship
- Internal Medicine, Cambridge Hospital
Degree
- MD, University of Missouri at Columbia
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 42 reviews
- March 25, 20265 out of 5 Stars
My doctor is the GOAT
- March 24, 20265 out of 5 Stars
Very friendly and easy to talk to.
- March 19, 20265 out of 5 Stars
Dr Guy is not only thorough, but she asks pertinent questions and listens to my concerns
- March 14, 20265 out of 5 Stars
Dr Guy is a fabulous Dr. She listens, cares, and gives great advice.
- February 11, 20265 out of 5 Stars
Dr. Michelle Guy has been my provider for several years and she has been one of the most attentive, respectful, informative, caring and down-to-earth clinicians I've ever been blessed to work with. I'm so grateful to be working with her as I navigate my weight loss journey. She's incredible.
- February 7, 20265 out of 5 Stars
Dr. Guy is a terrific partner in my care. I'm grateful to be her patient.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.